Nichols, David E. “Commentary On: Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance.” Psychopharmacology 187, no. 3 (2006): 284–86. doi:10.1007/s00213-006-0457-5.
Nichols, David E. “LSD: Cultural Revolution and Medical Advances.” Chemistry World 3, no. 1 (2006): 30–34.
Nichols, David E. “Psychedelics.” Pharmacological Reviews 68, no. 2 (2016): 264–355.
Nour, Matthew M., Lisa Evans, and Robin L. Carhar-Harris. “Psychedelics, Personality and Political Perspectives.” Journal of Psychoactive Drugs (2017): 1–10.
Novak, Steven J. “LSD Before Leary: Sidney Cohen’s Critique of 1950s Psychedelic Drug Research.” History of Science Society 88, no. 1 (1997): 87–110.
Nutt, David. “A Brave New World for Psychology?” Psychologist 27, no. 9 (2014): 658–60. doi:10.1097/NMD.0000000000000113.
Nutt, David. Drugs Without the Hot Air: Minimising the Harms of Legal and Illegal Drugs. Cambridge, England: UIT Cambridge, 2012.
Osmond, Humphry. “On Being Mad.” Saskatchewan Psychiatric Services Journal 1, no. 2
(1952).
Osmond, Humphry. “A Review of the Clinical Effects of Psychotomimetic Agents.” Annals of the New York Academy of Sciences 66, no. 1 (1957): 418–34.
Pahnke, Walter, “The Psychedelic Mystical Experience in the Human Encounter with Death.” Harvard Theological Review 62, no. 1 (1969): 1–22.
“Pass It On”: The Story of Bill Wilson and How the A.A. Message Reached the World. New York: Alcoholics Anonymous World Services, 1984.
Petri, G., P. Expert, F. Turkheimer, R. Carhart-Harris, D. Nutt, P. J. Hellyer, and F. Vaccarino. “Homological Scaffolds of Brain Functional Networks.” Journal of the Royal Society Interface 11, no. 101 (2014).
Piff, Paul K., Pia Dietze, Matthew Feinberg, Daniel M. Stancato, and Dacher Keltner. “Awe, the Small Self, and Prosocial Behavior.” Journal of Personality and Social Psychology 108, no. 6 (2015): 883–99. doi:10.1037/pspi0000018.
Pollan, Michael. “The Trip Treatment.” New Yorker, Feb. 9, 2015.
Preller, Katrin H., Marcus Herdener, Thomas Pokorny, Amanda Planzer, Rainer Krahenmann, Philipp Stдmpfli, Matthias E. Liechti, Erich Seifritz, and Franz X. Vollenweider. “The Fabric of Meaning and Subjective Effects in LSD-induced States Depend on Serotonin 2A Receptor Activation.” Current Biology 27, no. 3 (2017): 451–57.
Presti, David, and Jerome Beck. “Strychnine and Other Enduring Myths: Expert and User Folklore Surrounding LSD.” In Psychoactive Sacramentals: Essays on Entheogens and Religion, edited by Thomas B. Roberts, 125–35. San Francisco: Council on Spiritual Practices, 2001.
Raichle, Marcus E. “The Brain’s Dark Energy.” Scientific American 302, no. 3 (2010): 44–49. doi:10.1038/scientificamerican0310-44.
Raichle, Marcus E., Ann Mary MacLeod, Abraham Z. Snyder, William J. Powers, Debra A. Gusnard, and Gordon L. Shulman. “A Default Mode of Brain Function.” Proceedings of the National Academy of Sciences 98, no. 2 (2001): 676–82. doi:10.1073/pnas.98.2.676.
R.C. “B.C.’s Acid Flashback.” Vancouver Sun, Dec. 8, 2001.
Richards, William, Stanislav Grof, Louis Goodman, and Albert Kurland. “LSD-Assisted Psychotherapy and the Human Encounter with Death.” Journal of Transpersonal Psychology 4, no. 2 (1972): 121–50.
Samorini, Giorgio. Animals and Psychedelics: The Natural World and the Instinct to Alter Consciousness. Rochester, Vt.: Park Street Press, 2002.
Schuster, Charles R. “Commentary On: Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance.” Psychopharmacology 187, no. 3 (2006): 289–90. doi:10.1007/s00213-006-0457-5.
Schwartz, Casey. “Molly at the Marriott: Inside America’s Premier Psychedelics Conference.” New York Times, May 6, 2017.
Siff, Stephen. Acid Hype: American News Media and the Psychedelic Experience. Urbana: University of Illinois Press, 2015.
Simard, Suzanne W., David A. Perry, Melanie D. Jones, David D. Myrold, Daniel M. Durall, and Randy Molina. “Net Transfer of Carbon Between Ectomycorrhizal Tree Species in the Field.” Nature 388 (1997): 579–82.
Smith, Huston. Cleansing the Doors of Perception: The Religious Significance of Entheogenic
Plants and Chemicals. New York: Jeremy P. Tarcher/Putnam, 2000.
Smith, Huston. The Huston Smith Reader. Edited by Jeffery Paine. Berkeley: University of California Press, 2012.
Smith, Robert Ellis. “Psychologists Disagree on Psilocybin Research.” Harvard Crimson, March 15, 1962.
Solomon, Andrew. The Noonday Demon: An Atlas of Depression. New York: Scribner, 2015.
Srinivasan, Mandyam V. “Honey Bees as a Model for Vision, Perception, and Cognition.” Annual Review of Entomology 55, no. 1 (2010): 267–84. doi:10.1146/annurev.ento.010908.164537.
Stamets, Paul. Psilocybin Mushrooms of the World. Berkeley, Calif.: Ten Speed Press, 1996.
Stevens, Jay. Storming Heaven: LSD and the American Dream. New York: Grove Press, 1987.
Stolaroff, Myron J. The Secret Chief Revealed. Sarasota, Fla.: Multidisciplinary Association for Psychedelic Studies, 2004.
Strauss, Neil. Everyone Loves You When You’re Dead: Journeys into Fame and Madness. E-Book, 2011.
Sullivan, Walter. “The Einstein Papers. A Man of Many Parts,” New York Times, March 29, 1972.
Sutton, Gregory P., Dominic Clarke, Erica L. Morley, and Daniel Robert. “Mechanosensory Hairs in Bumblebees (Bombus terrestris) Detect Weak Electric Fields.” Proceedings of the National Academy of Sciences 113, no. 26 (2016): 7261–65. doi:10.1073/pnas.1601624113.
Tennyson, Alfred. “Luminous Sleep.” The Spectator, Aug. 1, 1903.
Tierney, John. “Hallucinogens Have Doctors Tuning In Again.” New York Times, April 12, 2010.
U.S. Congress Senate Subcommittee on Executive Reorganization of the Committee on Government Operations: Hearing on the Organization and Coordination of Federal Drug Research and Regulatory Programs: LSD. 89th Cong., 2nd sess., May 24–26, 1966.
Vollenweider, Franz X., and Michael Kometer. “The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Mood Disorders.” Nature Reviews Neuroscience 11, no. 9 (2010): 642–51. doi:10.1038/nrn2884.
Vollenweider, Franz X., Margreet F. I. Vollenweider-Scherpenhuyzen, Andreas Bäbler, Helen Vogel, and Daniel Hell. “Psilocybin Induces Schizophrenia-Like Psychosis in Humans via a Serotonin-2 Agonist Action.” NeuroReport 9, no. 17 (1998): 3897–902. doi:10.1097/00001756-199812010-00024.
